Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Diabetic Gastroparesis Treatment Market: By Type: Surgical Treatment Products, Drugs; By Disease Indication: Compensated Gastroparesis, Gastric Failure, Others; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Diabetic Gastroparesis Treatment Market Outlook
The global diabetic gastroparesis treatment market attained a value of about USD 4 billion in 2020. The market is expected to grow at a CAGR of 4% in the forecast period of 2022-2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advancements in Healthcare and Gastric Treatments to Aid the Market Growth of Diabetic Gastroparesis Treatment
The market for diabetic gastroparesis treatment is being driven by the improvements in the arena of healthcare and gastric treatments. The market is further aided by the growing cases of diabetes across the globe. Further, the existence of a seamless healthcare industry lays emphasis on the swift treatment and diagnosis, which is also propelling the market forward. Diabetic gastroparesis severely affects the quality of life. Therefore, medical practitioners are showing tremendous concern for the patient while treating such disorders, consequently enhancing the market growth. In addition, the availability of dieticians and professionals who can advise the patient regarding proper food consumption and food habits is also contributing to the market growth of diabetic gastroparesis treatment. All these factors are expected to support the market growth over the forecast period as well.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Diabetic Gastroparesis Treatment: Market Segmentation
Diabetic gastroparesis treatment is the treatment for delayed gastric emptying related to diabetes. The condition is observed in patients suffering from type-1 and type-2 diabetes and is found to be frequent in female patients that are suffering from type-2 diabetes.
On the basis of type, the market is divided into:
- Surgical Treatment Products
- Drugs
Based on disease indication, the industry can be segmented into:
- Compensated Gastroparesis
- Gastric Failure
- Others
By distribution channel, the industry is categorised into:
- Hospital Pharmacies
- Drug Stores
- Private Clinics
- Retail Pharmacies
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Cases of Diabetes to Aid the Market Growth of Diabetic Gastroparesis Treatment
The diabetic gastroparesis treatment industry is being driven by the need to meet the evolving demands within the diabetic treatment and diagnostics sector. The market is further aided by the rising cases of type-I and type-II diabetes. Furthermore, the rising demand for minimally invasive treatments and surgeries for the diabetic gastroparesis is also providing an impetus to the market growth as it has created significant growth opportunities within the industry. Moreover, the development of new drug lines within the industry is expected to boost the market growth of diabetic gastroparesis treatment over the forecast period.
Key Industry Players in the Global Diabetic Gastroparesis Treatment Market
The report gives a detailed analysis of the following key players in the global diabetic gastroparesis treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Evoke Pharma, Inc.
- Allergan plc
- Salix Pharmaceuticals
- Theravance Biopharma, Inc.
- Medtronic, plc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Disease Indication, Distribution Channel, Region |
| Breakup by Type | Surgical Treatment Products, Drugs |
| Breakup by Disease Indication | Compensated Gastroparesis, Gastric Failure, Others |
| Breakup by Distribution Channel | Hospital Pharmacies, Drug Stores, Private Clinics, Retail Pharmacies, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Evoke Pharma, Inc., Allergan plc, Salix Pharmaceuticals, Theravance Biopharma, Inc., Medtronic, plc, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Diabetic Gastroparesis Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Diabetic Gastroparesis Treatment Historical Market (2017-2021)
8.3 Global Diabetic Gastroparesis Treatment Market Forecast (2022-2027)
8.4 Global Diabetic Gastroparesis Treatment Market by Type
8.4.1 Surgical Treatment Products
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Drugs
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.5 Global Diabetic Gastroparesis Treatment Market by Disease Indication
8.5.1 Compensated Gastroparesis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Gastric Failure
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Others
8.6 Global Diabetic Gastroparesis Treatment Market by Distribution Channel
8.6.1 Hospital Pharmacies
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Drug Stores
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Private Clinics
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Retail Pharmacies
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2017-2021)
8.6.4.3 Forecast Trend (2022-2027)
8.6.5 Others
8.7 Global Diabetic Gastroparesis Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Evoke Pharma, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Allergan plc
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Salix Pharmaceuticals
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Theravance Biopharma, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Medtronic, plc
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Diabetic Gastroparesis Treatment Market: Key Industry Highlights, 2016 and 2026
2. Global Diabetic Gastroparesis Treatment Historical Market: Breakup by Type (USD Billion), 2017-2021
3. Global Diabetic Gastroparesis Treatment Market Forecast: Breakup by Type (USD Billion), 2022-2027
4. Global Diabetic Gastroparesis Treatment Historical Market: Breakup by Disease Indication (USD Billion), 2017-2021
5. Global Diabetic Gastroparesis Treatment Market Forecast: Breakup by Disease Indication (USD Billion), 2022-2027
6. Global Diabetic Gastroparesis Treatment Historical Market: Breakup by Distributional Channel (USD Billion), 2017-2021
7. Global Diabetic Gastroparesis Treatment Market Forecast: Breakup by Distributional Channel (USD Billion), 2022-2027
8. Global Diabetic Gastroparesis Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
9. Global Diabetic Gastroparesis Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
10. North America Diabetic Gastroparesis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11. North America Diabetic Gastroparesis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12. Europe Diabetic Gastroparesis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13. Europe Diabetic Gastroparesis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Asia Pacific Diabetic Gastroparesis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Asia Pacific Diabetic Gastroparesis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Latin America Diabetic Gastroparesis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Latin America Diabetic Gastroparesis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Middle East and Africa Diabetic Gastroparesis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Middle East and Africa Diabetic Gastroparesis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Global Diabetic Gastroparesis Treatment Market Structure
Key Questions Answered in the Report
In 2020, the global diabetic gastroparesis treatment market attained a value of nearly USD 4 billion.
The market is projected to grow at a CAGR of 4% between 2021 and 2026.
The major drivers of the industry, such as rising disposable incomes, increasing population, growing improvements in the arena of healthcare and gastric treatments, rising prevalence of diabetes, increasing availability of dieticians and professionals, and growing demand for minimally invasive treatments and surgeries for the diabetic gastroparesis, are expected to aid the market growth.
The key trends guiding the growth of the market include the rising development of new drugs and advancements in the healthcare industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading types of diabetic gastroparesis treatment in the industry are surgical treatment products and drugs.
The major disease indications in the market are compensated gastroparesis and gastric failure, among others.
The significant distribution channels in the industry are hospital pharmacies, drug stores, private clinics, and retail pharmacies, among others.
The major players in the industry are Evoke Pharma, Inc., Allergan plc, Salix Pharmaceuticals, Theravance Biopharma, Inc., and Medtronic, plc, among others.
Analyst Review
The global diabetic gastroparesis treatment market attained a value of USD 4 billion in 2020, driven by the rising occurrence of diabetes. Aided by the advancements in the healthcare infrastructure, the market is expected to witness a moderate growth in the forecast period of 2022-2027, growing at a CAGR of 4%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the market is segmented into surgical treatment products and drugs. On the basis of disease indication, the industry is divided into compensated gastroparesis and gastric failure, among others. The major distribution channels in the market are hospital pharmacies, drug stores, private clinics, and retail pharmacies, among others. The major regional markets for diabetic gastroparesis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Evoke Pharma, Inc., Allergan plc, Salix Pharmaceuticals, Theravance Biopharma, Inc., and Medtronic, plc, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global bleeding disorders therapeutics market was driven by the increasing focus on recombinant products by pharmaceutical companies in the historical period. Aided by the increasing awareness and...
India peritoneal dialysis market is driven by increasing government initiatives and guidelines. Aided by the surge in incidences of kidney-related diseases and the increasing geriatric population, the...
The global cystic fibrosis market attained a value of nearly USD 6.6 billion in 2021, driven by the increasing cases of cystic fibrosis. Aided by the innovative drug developments, the market is expect...
The Asia Pacific scoliosis management market was driven by the increasing demand for non-invasive therapies in the historical period. Aided by the high adoption rate of braces and advancement of techn...
The global craniomaxillofacial implants market attained a value of USD 2.5 billion in 2021, driven by the increase in the number of trauma cases and road accidents. Aided by the growing sports injurie...
NEWSLETTER